Delivery Order SPE2DB24D1021-SPE2DB25FFARX
- Not listed
- The Defense Logistics Agency awarded a $1,738.12 delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Prograf 1 mg capsules (100-count units). This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $27,638.41 to AmerisourceBergen Drug Corp for the supply of Prograf 1 mg capsules (100-count units) with a completion date of August 25, 2025. This is a firm fixed-price delivery order under a non-set-aside competition, with performance to be executed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills...
- The Defense Logistics Agency awarded a delivery order valued at $4,131.74 to AmerisourceBergen Drug Corp for the supply of Prograf 1 mg capsules (100-count units). This firm fixed-price delivery order, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a competitive award with no set-aside designation. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $41,735.37 to AmerisourceBergen Drug Corp for the supply of Prograf 5 mg capsules (100 count units) under a firm fixed price contract. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside award represents a competitively awarded transaction for a critical pharmaceutical...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $21,082.84 to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of 4565966189 - PROGRAF 1 MG CAPSULE 100S, a pharmaceutical product, with a period of performance through September 30, 2024. This contract award is part of a larger indefinite delivery contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The $7,004.70 firm fixed price delivery order is for the supply of PROGRAF 1 MG CAPSULE 100S, a medication likely used in the treatment of medical conditions. The contract has an ultimate completion date of July 7, 2025. Amerisourcebergen Drug Corp holds a larger...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide 4,565,736 units of the prescription medication Prograf 1 mg capsules. The order is a firm fixed-price contract valued at $15,062.59 and will be delivered by September 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,752.52, is for the delivery of Prograf 1 mg capsules, a medication used for organ transplant patients. The contract is a firm fixed-price, non-set-aside award with a performance period through April 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- This federal contract award is a delivery order worth $1,589.62 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of PROGRAF 1 MG CAPSULE 100S, a pharmaceutical product, with a period of performance through October 28, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,446.03 firm fixed-price delivery order is for the supply of PROGRAF 1 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of January 2, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFARXDelivery Order
The Defense Logistics Agency (DLA) awarded a $1,303.59 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Prograf 1 mg capsules (100-unit quantity). This firm fixed price contract, with an ultimate completion date of September 16, 2025, represents a non-set-aside competitive award to be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of medications and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates capability across diverse therapeutic domains, including specialty medications, brand-name and generic pharmaceuticals, vaccines, and medical devices. This delivery order for Prograf, an immunosuppressant medication commonly used in transplant patients, exemplifies the company's role in supplying essential pharmaceutical products through DLA's medical supply chain to support military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/15/25 |